AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEUROSCIENTIFIC BIOPHARMACEU

0.130

-0.010-7.14%

Volume:100.70K

Turnover:13.14K

Market Cap:43.23M

PE:-10.32

High:0.140

Open:0.140

Low:0.130

Close:0.140

52wk High:0.260

52wk Low:0.034

Shares:332.58M

Float Shares:243.14M

Volume Ratio:0.59

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.013

EPS(LYR):-0.013

ROE:-16.65%

ROA:-11.21%

PB:2.57

PE(LYR):-10.33

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BUZZ-Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results

BRIEF-Neuroscientific Biopharmaceuticals Requests Trading Halt

NeuroScientific Biopharmaceuticals - Requests Halt Pending Special Access Program Results

THOMSON REUTERS

NeuroScientific Biopharmaceuticals Ltd-Investor Webinar Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NSB.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NSB.AU\",,,,,undefined,":{"symbol":"NSB.AU","market":"AU","secType":"STK","nameCN":"NEUROSCIENTIFIC BIOPHARMACEU","latestPrice":0.13,"timestamp":1770354720000,"preClose":0.14,"halted":0,"volume":100701,"delay":0,"changeRate":-0.07142857142857148,"nameEN":"NEUROSCIENTIFIC BIOPHARMACEU","floatShares":243142540,"shares":332575706,"eps":-0.0126,"marketStatus":"Market Closed","change":-0.01,"latestTime":"02-06 16:12:00 AEDT","open":0.14,"high":0.14,"low":0.13,"amount":13135,"amplitude":0.071429,"askPrice":0.14,"askSize":8220,"bidPrice":0.13,"bidSize":159696,"shortable":3,"etf":0,"ttmEps":-0.0126,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.14,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":0.5922668474145033,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NSB.AU\",,,,,undefined,":{"symbol":"NSB.AU","floatShares":243142540,"roa":"-11.21%","roe":"-16.65%","lyrEps":-0.012583,"volumeRatio":0.5922668474145033,"shares":332575706,"dividePrice":0,"high":0.14,"amplitude":0.071429,"preClose":0.14,"low":0.13,"week52Low":0.034,"pbRate":"2.57","psRate":"260.33","week52High":0.26,"institutionHeld":0,"latestPrice":0.13,"committee":0.902094,"eps":-0.0126,"divideRate":0,"volume":100701,"delay":0,"ttmEps":-0.0126,"open":0.14,"prevYearClose":0.11,"prevWeekClose":0.14,"prevMonthClose":0.14,"prevQuarterClose":0.11,"fiveDayClose":0.14,"twentyDayClose":0.115,"sixtyDayClose":0.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NSB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NSB.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603757667","title":"BUZZ-Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results","url":"https://stock-news.laohu8.com/highlight/detail?id=2603757667","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603757667?lang=en_us&edition=fundamental","pubTime":"2026-01-13 10:47","pubTimestamp":1768272464,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results** Shares of NeuroScientific Biopharmaceuticals NSB.AX rise as much as 52.2% to A$0.175, their highest level since September 24, 2025** Biopharmaceutical co heading for best day since April 2025, if current gains hold** Co announces successful clinical results from fistulising crohn's disease patients treated with its StemSmart mesenchymal stem cell therapy** Says three of four patients demonstrated successful clinical response when treated with StemSmart** About 4.3 mln shares change hands, 25.7x the 30-day average, in the busiest day since July 24, 2025** Stock more than tripled in value last year   ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL6N3YE06N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","NSB.AU"],"gpt_icon":0},{"id":"2602315770","title":"BRIEF-Neuroscientific Biopharmaceuticals Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2602315770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602315770?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:28","pubTimestamp":1767911336,"startTime":"0","endTime":"0","summary":"BRIEF-Neuroscientific Biopharmaceuticals Requests Trading Halt Jan 9 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX:REQUESTS HALT PENDING SPECIAL ACCESS PROGRAM RESULTSFurther company coverage: NSB.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y90GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","NSB.AU"],"gpt_icon":0},{"id":"2602731577","title":"NeuroScientific Biopharmaceuticals - Requests Halt Pending Special Access Program Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2602731577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602731577?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:28","pubTimestamp":1767911308,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y90GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NSB.AU"],"gpt_icon":0},{"id":"2582313277","title":"NeuroScientific Biopharmaceuticals Ltd-Investor Webinar Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582313277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582313277?lang=en_us&edition=fundamental","pubTime":"2025-11-12 07:00","pubTimestamp":1762902046,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUEP52KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NSB.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NSB.AU\",params:#limit:6,delay:true,,,undefined,":[]}}